FDA Inspection 1205546 — USpharma, Ltd.

USpharma, Ltd. — FEI 1010370

The FDA completed an inspection of USpharma, Ltd. on May 11, 2023 in Miami Lakes, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 11, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Miami Lakes, FL (United States)

Citations

IDCFRDescription
73121 CFR 803.50(a)(1)Report of Death or Serious Injury